PCCA and Eagle Award Their 2021 Team Members of the Year
21 févr. 2022 15h21 HE
|
PCCA
Houston, Feb. 21, 2022 (GLOBE NEWSWIRE) -- PCCA and Eagle recently named three outstanding individuals as their 2021 Team Members of the Year. Micheal Jones, PCCA Human Relations Specialist, was...
Bryan Ziegler, PharmD, MBA, Receives the 2021 George Roentsch, RPh, New Innovator Award from PCCA
26 oct. 2021 11h12 HE
|
PCCA
Houston, Texas, Oct. 26, 2021 (GLOBE NEWSWIRE) -- PCCA has named Bryan Ziegler, PharmD, MBA, of Moss Compounding Pharmacy, Florence, South Carolina, as the recipient of the 2021 George Roentsch,...
PCCA Honors Vincent M. Canzanese, RPh, as the 2021 Compounding Pharmacist of the Year
25 oct. 2021 15h12 HE
|
PCCA
Houston, Texas, Oct. 25, 2021 (GLOBE NEWSWIRE) -- PCCA has named Vincent M. Canzanese, RPh, of Summit Health Pharmacy, Brookhaven, Pennsylvania, as its 2021 M. George Webber, PhD, Compounding...
PCCA Honors Jeffery R. Bray with the 2021 L. David Sparks Advocacy Award
22 oct. 2021 12h37 HE
|
PCCA
Houston, Texas, Oct. 22, 2021 (GLOBE NEWSWIRE) -- PCCA has honored Jeffery R. Bray, MBA, MAED, SHRM-SCP, as the first recipient of the L. David Sparks Advocacy Award. Named for PCCA’s chief...
Ryan Waldschmidt Wins PCCA’s 2021 International Seminar Pharmacy Student Scholarship Contest
12 oct. 2021 10h17 HE
|
PCCA
Houston, Oct. 12, 2021 (GLOBE NEWSWIRE) -- PCCA has selected pharmacy student Ryan Waldschmidt as the winner of its 2021 International Seminar Pharmacy Student Scholarship Contest. On Saturday,...
PCCA Takes Home Two AMA Houston 2021 Crystal Awards for #CompoundingHandoff Campaign
26 mai 2021 10h32 HE
|
PCCA
Houston, Texas, May 26, 2021 (GLOBE NEWSWIRE) -- PCCA received multiple honors at the 35th Annual Crystal Awards Gala held by the Houston Chapter of the American Marketing Association (AMA Houston)...
Tiziana Life Sciences announces presentation of StemPrintER, a superior prognostic test as compared to Oncotype DX to predict breast cancer
29 mai 2020 02h00 HE
|
Tiziana Life Sciences PLC
StemPrintER Outperforms Oncotype DX in analysis with 800+ samples from ER+/HER2- postmenopausal breast cancer patientsSPARE Model is up to 40-50% more accurate than standard clinical markers in...